Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAS181 for severe hospitalized influenza and non-influenza respiratory viral infection
CTR20200279Phase 2Active
- Sponsor
- Ansun Biopharma
- Start
- Mar 2020
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of DAS181 in influenza, Respiratory viral illness, sponsored by Ansun Biopharma. Started Mar 2020; status: active.
02
Drugs
DAS181
03
Conditions
influenzaRespiratory viral illness
Beyond the preview
Go deeper on CTR20200279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200279.